Description
The U.S. Food and Drug Administration (FDA) is seeking information from potential sources for a Life Technologies Quantstudio 7 Flex Real-Time PCR (qPCR) Service Agreement. The agreement will cover a Base Year plus two possible option years, starting on August 15, 2026. The service agreement should include preventative maintenance and unlimited corrective repair services for the instrument, as well as priority response time and remote support. Interested parties should submit capability statements, including business information, descriptive literature, past performance data, and technical information.
• The service agreement should cover the Life Technologies Quantstudio 7 Flex Real-Time PCR (qPCR) instrument, serial number 278871548.
• The agreement should include one preventative maintenance inspection per service agreement year.
• The service provider should have guaranteed priority response time of 2 business days after receipt of a service call.
• The service provider should have OEM formally trained and certified technicians/engineers for all maintenance and repair activities.
• The service provider should provide a written report to the FDA COR and Contract Specialist, summarizing all maintenance activities each time service is performed.